A Rare Case of Guillain-Barre Syndrome Due to Disseminated CMV Infection in a Kidney Transplant Recipient

2013 ◽  
Vol 61 (4) ◽  
pp. B63
2021 ◽  
pp. 1-5
Author(s):  
Amr Hassan ◽  
Alaa El-Mazny ◽  
Mohammed Saher ◽  
Ismail Ibrahim Ismail ◽  
Mohammed Almuqbil

Guillain-Barre syndrome (GBS) and multiple sclerosis (MS) are autoimmune demyelinating disorders of the peripheral and central nervous systems, respectively. The co-occurrence of these 2 conditions is rare in the literature. Herein, we present a rare case of GBS and MS in a 19-year-old female who presented initially with GBS followed by MS, and we provide a literature review. Despite being rare, it should be kept in mind in the differential diagnosis of patients with atypical and usual presentation of both diseases.


2021 ◽  
Vol 0 (0) ◽  
pp. 0
Author(s):  
PushpendraN Renjen ◽  
Shishir Pandey ◽  
Dinesh Chaudhari ◽  
Kamal Ahmad

2020 ◽  
Vol Volume 13 ◽  
pp. 543-549
Author(s):  
Raid Kofahi ◽  
Belal Aldabbour ◽  
Ma'en Aljezawi

2014 ◽  
Vol 2014 ◽  
pp. 1-5 ◽  
Author(s):  
Saivaralaxmi Monaganti ◽  
Carlos A. Q. Santos ◽  
Andrea Markwardt ◽  
Morgan A. Pence ◽  
Daniel C. Brennan

We report a rare case of pulmonary phaeohyphomycosis in a 49-year-old woman 6 years after kidney transplantation. She presented with dyspnea, cough, and fatigue. Her chest CT scan revealed nodular opacities in the right upper lung. A fine needle aspirate biopsy culture yieldedPhaeoacremoniumand surgical pathology of the biopsy showed chronic inflammation. We successfully treated her with posaconazole and managed drug interactions between posaconazole and tacrolimus. This is the second reported case of biopsy-proven pulmonary infection byPhaeoacremoniumin a kidney transplant recipient and successfully treated with posaconazole.


2016 ◽  
Vol 41 (1) ◽  
pp. 41-47 ◽  
Author(s):  
Aravindhan Baheerathan ◽  
Amy Ross Russell ◽  
Fion Bremner ◽  
Simon F. Farmer

Author(s):  
Yash Kripalani ◽  
Vidyadhara Lakkappan ◽  
Lipeeka Parulekar ◽  
Anjum Shaikh ◽  
Rakesh Singh ◽  
...  

Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. Their emergency administration in healthcare settings has been accompanied by numerous adverse effects. A case of Guillain-Barré syndrome following vaccination with Covishield is presented here to highlight this possible adverse condition.


2021 ◽  
Vol 79 (7) ◽  
pp. 607-611
Author(s):  
Mario Emilio Teixeira Dourado Junior ◽  
Bruno Fernandes de Sousa ◽  
Nathaly M. Coelho da Costa ◽  
Selma Maria Bezerra Jeronimo

ABSTRACT Background: Guillain-Barré syndrome (GBS) is currently the most common cause of acute flaccid paralysis worldwide. Risk factors for GBS include previous viral or bacterial infections or vaccination. Recently, an outbreak of Zika virus led to an outbreak of GBS in Latin America, mostly in Brazil, concomitant to continuous circulation of dengue virus serotypes. However, there is no study about cytomegalovirus (CMV) infection as a risk for GBS in Brazil. Objectives: In this study, we report a series of cases of GBS with the aim of determining the prevalence of CMV and the characteristics associated with the infection. Methods: A cohort of 111 GBS cases diagnosed between 2011 and 2017 in Natal, northeastern Brazil, was studied. Presence of CMV IgM antibodies was determined by means of electrochemiluminescence. The analysis was performed considering CMV infection status and the clinical outcome. Results: We found seroprevalence of 15.3% (n = 17) for CMV. CMV patients were younger (26 vs. 40; p = 0.016), with no apparent gastrointestinal (p = 0.762) or upper respiratory infections (p = 0.779) or sensory loss (p = 0.03). They presented more often with a classic GBS sensorimotor variant (p = 0.02) and with a demyelinating pattern in electrophysiological studies (p < 0.001). Conclusion: In Brazil, the clinical-epidemiological profile of GBS associated with CMV infection is similar to that described in other countries. Better understanding of the relationship between infectious processes and GBS is a key component of the research agenda and assistance strategy for global health initiatives relating to peripheral neuropathic conditions.


Sign in / Sign up

Export Citation Format

Share Document